Early serum carcinoembryonic antigen reduction predicts tumor shrinkage and overall survival in colorectal cancer patients with distant metastasis, after primary surgery followed by mFOLFOX6 plus bevacizumab treatment
Early serum carcinoembryonic antigen reduction predicts tumor shrinkage and overall survival in colorectal cancer patients with distant metastasis, after primary surgery followed by mFOLFOX6 plus bevacizumab treatment
复制标题
早期血清癌胚抗原减少可预测远处转移结直肠癌患者在初次手术后接受 mFOLFOX6 加贝伐珠单抗治疗后的肿瘤缩小和总体生存率
DOI：
--
复制
发表时间：
2014
期刊：
影响因子：
--
通讯作者：
Hiroyuki Kato.
中科院分区：
文献类型：
--
作者：
Satoru Yamaguchi;Hideo Ogata;Daisuke Katsumata;Masanobu Nakajima;Takaaki Fujii;Soichi Tsutsumi;Takayuki Asao;Kinro Sasaki;Hiroyuki Kuwano;Hiroyuki Kato.
